Biocon has added to its roster of liraglutide partners by striking a fresh deal in Korea with Handok for the chronic weight management treatment.
Biocon has notched up yet another partnership deal on liraglutide, striking an agreement with Korean firm Handok for its generic version of the chronic weight management treatment.
Underlining the “vertically integrated, complex” nature of the product, Biocon said that under the agreement with Handok, the Indian firm...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
